Evidence map›Paper›PMID 38958945›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2025

Contribution of Prediagnostic Host Factors to Shaping the Stromal Microenvironment of Breast Cancer among Sub-Saharan African Women.

Mustapha Abubakar, Thomas U Ahearn, Maire A Duggan, Scott Lawrence, Ernest K Adjei, Joe-Nat Clegg-Lamptey, Joel Yarney, Beatrice Wiafe-Addai, Baffour Awuah, Seth Wiafe and 10 more

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Unveiling the Stroma: Reproductive Factors and the Tumor Microenvironment in African Breast Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Mustapha AbubakarDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0003-3728-6535
Thomas U AhearnDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0003-0771-7752
Maire A DugganDepartment of Pathology and Laboratory Medicine, University of Calgary, Calgary, Canada.ORCID 0000-0001-6625-7683
Scott LawrenceMolecular and Digital Pathology Laboratory, Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick, Maryland.ORCID 0000-0002-5297-7978
Ernest K AdjeiKomfo Anokye Teaching Hospital, Kumasi, Ghana.ORCID 0000-0002-4004-3334
Joe-Nat Clegg-LampteyKorle Bu Teaching Hospital, Accra, Ghana.ORCID 0000-0003-0497-071X
Joel YarneyKorle Bu Teaching Hospital, Accra, Ghana.ORCID 0000-0002-4048-2935
Beatrice Wiafe-AddaiPeace and Love Hospital, Kumasi, Ghana.ORCID 0000-0001-7031-7335
Baffour AwuahKomfo Anokye Teaching Hospital, Kumasi, Ghana.ORCID 0000-0002-2371-1695
Seth WiafeLoma Linda University, School of Public Health, Loma Linda, California.ORCID 0000-0001-6085-9405
Kofi NyarkoUniversity of Ghana, Accra, Ghana.ORCID 0000-0002-1657-3167
Francis S AitpillahKomfo Anokye Teaching Hospital, Kumasi, Ghana.ORCID 0000-0001-9495-6887
Daniel AnsongKwame Nkrumah University of Science and Technology, Kumasi, Ghana.ORCID 0000-0003-1328-9117
Stephen M HewittCenter for cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0001-8283-1788
Louise A BrintonDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0003-3853-8562
Jonine D FigueroaDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0002-5100-623X
Montserrat Garcia-ClosasDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0003-1033-2650
Lawrence EduseiKorle Bu Teaching Hospital, Accra, Ghana.ORCID 0000-0001-5323-0502
Nicolas TitiloyeKomfo Anokye Teaching Hospital, Kumasi, Ghana.ORCID 0000-0001-7578-5859
Ghana Breast Health Study Team

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Division of Cancer Epidemiology and Genetics (DCEG)NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundThe stromal microenvironment (SME) is integral to breast cancer biology, impacting metastatic proclivity and treatment response. Emerging data indicate that host factors may impact the SME, but the relationship between prediagnostic host factors and SME phenotype remains poorly characterized, particularly among women of African ancestry.

methodsWe conducted a case-only analysis involving 792 patients with breast cancer (17-84 years) from the Ghana Breast Health Study. High-accuracy machine-learning algorithms were applied to standard H&E-stained images to characterize SME phenotypes [including percent tumor-associated connective tissue stroma, Ta-CTS (%); tumor-associated stromal cellular density, Ta-SCD (%)]. Associations between prediagnostic host factors and SME phenotypes were assessed in multivariable linear regression models.

resultsDecreasing Ta-CTS and increasing Ta-SCD were associated with aggressive, mostly high-grade tumors (P-value < 0.001). Several prediagnostic host factors were associated with Ta-SCD independently of tumor characteristics. Compared with nulliparous women, parous women had higher levels of Ta-SCD [mean (standard deviation, SD) = 31.3% (7.6%) vs. 28.9% (7.1%); P-value = 0.01]. Similarly, women with a positive family history of breast cancer had higher levels of Ta-SCD than those without family history [mean (SD) = 33.0% (7.5%)] vs. 30.9% (7.6%); P-value = 0.03]. Conversely, increasing body size was associated with decreasing Ta-SCD [mean (SD) = 31.6% (7.4%), 31.4% (7.3%), and 30.1% (8.0%) for slight, average, and large body sizes, respectively; P-value = 0.005].

conclusionsEpidemiological risk factors were associated with varying degrees of stromal cellularity in tumors, independently of clinicopathological characteristics. IMPACT: The findings raise the possibility that epidemiological risk factors may partly influence tumor biology via the stromal microenvironment. See related In the Spotlight, p. 459.

Indexed as

Breast NeoplasmsStromal CellsTumor MicroenvironmentAdolescentAdultAgedAged, 80 and overFemaleGhanaHumansMiddle AgedYoung Adult

Identifiers

PMID38958945
PMCPMC11966112

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.